Business Context and Reporting Period
Company: OrthoPediatrics Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: August 8, 2018
Reporting Period: Quarter ended June 30, 2018
Status: Emerging Growth Company (Elected not to use extended transition period)
Key Financial Metrics
This Form 8-K serves as a notification of the earnings release and does not contain specific financial figures within the text provided. The filing states that unaudited condensed consolidated financial statements and other financial data are furnished as Exhibit 99.1 (Press Release dated August 8, 2018) and incorporated by reference.
- Revenue, Profit, Cash Flow, Margins, Debt, Liquidity: The filing text does not provide clear values for these metrics. Investors must refer to Exhibit 99.1 for specific numbers.
Material Changes
The filing does not detail specific material changes or comparative period analysis within the body of the 8-K. It directs readers to the press release (Exhibit 99.1) for the announcement of results and other disclosures.
Guidance, Outlook, and Risks
Management Commentary: The Company issued a press release on August 8, 2018, announcing earnings and making other disclosures. Specific commentary, guidance, or outlook is contained within Exhibit 99.1 and is not detailed in this summary text.
Risks and Contingencies: No specific risks or contingencies are described in the provided text of the 8-K.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for actual revenue, net income, and cash flow figures for the quarter ended June 30, 2018.
- Verify year-over-year and quarter-over-quarter performance metrics in the unaudited financial statements referenced in the press release.
- Check for any forward-looking statements or guidance updates included in the press release.
- Confirm the Company's status as an Emerging Growth Company and its election regarding accounting standard transition periods.